heudelotol A

from the roots of Dichapetalum heudelotii; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Chama, Mary Anti: 1 article (10/2017)
2.	Dziwornu, Godwin Akpeko: 1 article (10/2017)
3.	Osei-Safo, Dorcas: 1 article (10/2017)
4.	Salgado, Antonio: 1 article (10/2017)
5.	Sunassee, Suthananda Naidu: 1 article (10/2017)

1.	Neoplasms (Cancer) 10/01/2017 - "The new bisbibenzyls heudelotol A and B exhibited good activity against human pancreatic adenocarcinoma (GI50 9.04μM) and Burkitt's lymphoma (GI50 4.67μM) respectively, and average activity against the other cancer cell lines."
2.	Burkitt Lymphoma (Burkitt's Lymphoma) 10/01/2017 - "The new bisbibenzyls heudelotol A and B exhibited good activity against human pancreatic adenocarcinoma (GI50 9.04μM) and Burkitt's lymphoma (GI50 4.67μM) respectively, and average activity against the other cancer cell lines."
3.	Adenocarcinoma 10/01/2017 - "The new bisbibenzyls heudelotol A and B exhibited good activity against human pancreatic adenocarcinoma (GI50 9.04μM) and Burkitt's lymphoma (GI50 4.67μM) respectively, and average activity against the other cancer cell lines."